|
|
||||||||
Clinical Observations |
1 Department of Radiology, Kobe University Graduate School of Medicine, 7-5-2
Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
2 Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA
02215.
3 Department of Medical Engineering, Division of Allied Health Sciences, Osaka
University Medical School, Osaka, Japan.
OBJECTIVE. The purpose of this study was to determine whether quantitative pulmonary perfusion parameters obtained from 3D dynamic contrast-enhanced MR perfusion data can be used to assess the severity of primary pulmonary hypertension (PPH) as indicated by pulmonary vascular resistance (PVR) and mean pulmonary artery pressure (MPAP).
CONCLUSION. Three-dimensional dynamic contrast-enhanced MRI has potential for assessment of disease severity as indicated by PVR and MPAP in patients with PPH.
Keywords: chest lung MRI perfusion pulmonary hypertension
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. C. Champion, E. D. Michelakis, and P. M. Hassoun Comprehensive Invasive and Noninvasive Approach to the Right Ventricle-Pulmonary Circulation Unit: State of the Art and Clinical and Research Implications Circulation, September 15, 2009; 120(11): 992 - 1007. [Full Text] [PDF] |
||||
![]() |
L. E. R. McLure and A. J. Peacock Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension Eur. Respir. J., June 1, 2009; 33(6): 1454 - 1466. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |